223 related articles for article (PubMed ID: 28967904)
1. A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.
Chhabra Y; Wong HY; Nikolajsen LF; Steinocher H; Papadopulos A; Tunny KA; Meunier FA; Smith AG; Kragelund BB; Brooks AJ; Waters MJ
Oncogene; 2018 Jan; 37(4):489-501. PubMed ID: 28967904
[TBL] [Abstract][Full Text] [Related]
2. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
[TBL] [Abstract][Full Text] [Related]
3. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
[TBL] [Abstract][Full Text] [Related]
4. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.
Zhou Y; Zhang Z; Wang N; Chen J; Zhang X; Guo M; John Zhong L; Wang Q
Cell Death Dis; 2018 Apr; 9(4):429. PubMed ID: 29559623
[TBL] [Abstract][Full Text] [Related]
5. Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- mice.
Dobie R; MacRae VE; Huesa C; van't Hof R; Ahmed SF; Farquharson C
J Endocrinol; 2014 Oct; 223(1):93-106. PubMed ID: 25074853
[TBL] [Abstract][Full Text] [Related]
6. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
[TBL] [Abstract][Full Text] [Related]
7. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
8. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).
Bulatov E; Martin EM; Chatterjee S; Knebel A; Shimamura S; Konijnenberg A; Johnson C; Zinn N; Grandi P; Sobott F; Ciulli A
J Biol Chem; 2015 Feb; 290(7):4178-91. PubMed ID: 25505247
[TBL] [Abstract][Full Text] [Related]
9. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
Yang HL; Sun C; Sun C; Qi RL
Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase.
Kung WW; Ramachandran S; Makukhin N; Bruno E; Ciulli A
Nat Commun; 2019 Jun; 10(1):2534. PubMed ID: 31182716
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD).
Kostopoulou E; Rojas Gil AP; Spiliotis BE
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114520
[TBL] [Abstract][Full Text] [Related]
12. SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis.
Pass C; MacRae VE; Huesa C; Faisal Ahmed S; Farquharson C
J Bone Miner Res; 2012 May; 27(5):1055-66. PubMed ID: 22228213
[TBL] [Abstract][Full Text] [Related]
13. Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.
Kazi JU; Rönnstrand L
Mol Oncol; 2013 Jun; 7(3):693-703. PubMed ID: 23548639
[TBL] [Abstract][Full Text] [Related]
14. SOCS2 Silencing Improves Somatic Growth without Worsening Kidney Function in CKD.
Landau D; Assadi MH; Abu Hilal R; Chen Y; Rabkin R; Segev Y
Am J Nephrol; 2020; 51(7):520-526. PubMed ID: 32541140
[TBL] [Abstract][Full Text] [Related]
15. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness.
Ransome MI; Goldshmit Y; Bartlett PF; Waters MJ; Turnley AM
Eur J Neurosci; 2004 Apr; 19(8):2069-79. PubMed ID: 15090034
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
18. SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration.
Masuzaki R; Zhao S; Valerius MT; Tsugawa D; Oya Y; Ray KC; Karp SJ
J Biol Chem; 2016 Feb; 291(7):3346-58. PubMed ID: 26703468
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin ligase Cullin5
Paul I; Batth TS; Iglesias-Gato D; Al-Araimi A; Al-Haddabi I; Alkharusi A; Norstedt G; Olsen JV; Zadjali F; Flores-Morales A
Sci Rep; 2017 Feb; 7():42800. PubMed ID: 28216640
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
